Detalhe da pesquisa
1.
Cyclosporine A lipid nanoparticles for oral administration: Pharmacodynamics and safety evaluation.
Eur J Pharm Biopharm
; 101: 112-8, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26877154
2.
Lipid nanoparticles enhance the absorption of cyclosporine A through the gastrointestinal barrier: In vitro and in vivo studies.
Int J Pharm
; 500(1-2): 154-61, 2016 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26794875
3.
Reformulating cyclosporine A (CsA): More than just a life cycle management strategy.
J Control Release
; 225: 269-82, 2016 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26829101
4.
Cyclosporine A-loaded lipid nanoparticles in inflammatory bowel disease.
Int J Pharm
; 503(1-2): 196-8, 2016 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26972380
5.
Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity.
Int J Nanomedicine
; 10: 6541-53, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26527872